Onkos Surgical, a leading provider of innovative solutions for complex orthopaedic procedures, recently opened the NanoCept Innovation Center in Bridgewater.
“Onkos is proud to have worked with the FDA to bring to market the first antibacterial coating technology,” said Founder & CEO Patrick Treacy. “The opening of the NanoCept Innovation Center marks another important milestone in our company’s journey.
“This investment will allow us to get this groundbreaking technology into the hands of more surgeons, faster, and it puts us in a position to help more patients with complex orthopaedic conditions,” Treacy said.
The NanoCept Innovation Center will employ a team of chemists, engineers, and technicians in the new facility to lead its innovation operations. The company’s headquarters is at 77 East Halsey Road in Parsippany.
“I am excited by Onkos’ commitment to bring this technology to more implants and ultimately to more patients,” said Steven Gitelis, MD, Director of Rush University/MD Anderson’s Orthopaedic Oncology Program and Chief Medical Officer of Onkos.
“This is a unique technology that arms us, as surgeons, with a powerful solution to help mitigate the serious issue of bacteria in the operating room,” Gitelis said.
NJBIA Vice President of Government Affairs Althea D. Ford was among the dignitaries on hand Dec. 9 for the NanoCept Innovation Center's ribbon-cutting.
Other guests included Bridgewater Township Councilman Michael Kirsh; Erin D’Auria, District Director for Congressman Tom Kean, Jr. (R-NJ); John Coelho, Life Sciences Strategic Innovation Senior Advisor at New Jersey Economic Development Authority (NJEDA); and Jessica Paolini, Director of Economic Development for Somerset County.
Caption: Onkos Surgical's new NanoCept Innovation Center held a ribbon-cutting ceremony on Dec. 9. (L-R) Erin D’Auria, John Coelho, Gene Kulesha, Dr. Steven Gitelis, Michael Kirsh, Patrick Treacy, and Althea Ford. – Photo courtesy of Onkos Surgical.
